Bial Aristegui Overview

  • Status
  • Acquired/​Merged
  • Employees
  • 100
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3

Bial Aristegui General Information

Description

Manufacturer and seller of pharmaceutical products created to provide a complete therapeutic service for allergic immunotherapy. The company's pharmaceutical products are comprised of vaccines used for the treatment of allergic diseases and diagnostic tests enabling customers avail a complete product portfolio of immunotherapy products both in the form of injections (SCIT) as by means of administering drops under the tongue (SLIT).

Contact Information

Formerly Known As
Aristegui
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Acquirer
Roxall Medizin
Primary Office
  • Calle Clara del Rey nº 31, 1º planta
  • 28002 Madrid
  • Spain
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bial Aristegui Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bial Aristegui‘s full profile, request access.

Request a free trial

Bial Aristegui Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bial Aristegui Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Bial Aristegui‘s full profile, request access.

Request a free trial